Genedx Holdings 's Cash & cash equivalent grew by 28.34 % in the Q3 2026 sequentially, while Current Liabilities decreased, this led to improvement in Genedx Holdings 's Quick Ratio to 2.38, Quick Ratio remained below Genedx Holdings Corp average.

Within Medical Equipment & Supplies industry 85 other companies have achieved higher Quick Ratio than Genedx Holdings in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 1229 to 1521.

Explain Quick Ratio?
How much Cash & cash equivalents WGS�s has?
What are WGS�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/WGS/financial-strength

https://api.csimarket.com/api/v1/companies/WGS/fundamentals

https://api.csimarket.com/api/v1/companies/WGS/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

WGS Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	-14.17 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	9.7 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	2.38	Subscribe	Subscribe	Subscribe	Subscribe
WGS's Total Ranking	# 1521	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	-8.04 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	28.34 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 86
Healthcare Sector	# 531
Overall Market	# 1521

Quick Ratio Statistics
High	Average	Low
59.07	4.61	0.59
(Sep 30 2020)		(Jun 30 2021)

Financial Statements
Genedx Holdings 's Current Liabilities	$ 71 Millions	Visit WGS's Balance sheet
Genedx Holdings 's Cash & cash equivalent	$ 170 Millions	Visit WGS's Balance sheet
Source of WGS's Sales		Visit WGS's Sales by Geography

Cumulative Genedx Holdings 's Quick Ratio

WGS's Quick Ratio for the trailling 12 Months

WGS Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	17.45 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	9.26 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	1.92	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 3956	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	-3.39 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	2.39 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to WGS Financial Strength Comparisons >> Go to Compare WGS Quick Ratio to its Competitors

On the trailing twelve months basis WGS Cash & cash equivalent improved by 9.7 % in Q3 2026 year on year, while Current Liabilities decreased to $71 millions, this led to increase in in Genedx Holdings 's Quick Ratio to 1.92, above WGS average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 201 other companies have achieved higher Quick Ratio than Genedx Holdings . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3060 to 3956.

Explain Quick Ratio?
How much Cash & cash equivalents WGS�s has?
What are WGS�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 202
Healthcare Sector	# 893
Within the Market	# 3956

trailing twelve months Quick Ratio Statistics
High	Average	Low
3.48	1.61	0.99
(Mar 31 2022)		(Jun 30 2026)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Ceribell Inc	6.51	$ 117.467 Millions	$ 18.034 Millions
Autonomix Medical Inc	6.13	$ 7.692 Millions	$ 1.254 Millions
Iradimed Corporation	6.13	$ 63.288 Millions	$ 10.323 Millions
Orasure Technologies Inc	5.90	$ 148.238 Millions	$ 25.104 Millions
Perspective Therapeutics Inc	5.09	$ 201.695 Millions	$ 39.602 Millions
Beyond Air Inc	4.69	$ 17.121 Millions	$ 3.647 Millions
Clearpoint Neuro Inc	4.68	$ 46.184 Millions	$ 9.869 Millions
Cvrx inc	4.67	$ 58.746 Millions	$ 12.583 Millions
Heartbeam Inc	4.47	$ 6.065 Millions	$ 1.358 Millions
Dexcom Inc	4.25	$ 964.800 Millions	$ 227.000 Millions
Innovative Eyewear Inc	3.86	$ 3.197 Millions	$ 0.829 Millions
Sight Sciences Inc	3.84	$ 77.402 Millions	$ 20.137 Millions
Bluejay Diagnostics Inc	3.83	$ 7.380 Millions	$ 1.927 Millions
Alpha Pro Tech Ltd	3.78	$ 25.546 Millions	$ 6.750 Millions
Hyperfine Inc	3.60	$ 37.872 Millions	$ 10.532 Millions
Capsovision Inc	3.55	$ 21.757 Millions	$ 6.124 Millions
Profound Medical Corp	3.41	$ 33.343 Millions	$ 9.771 Millions
Rxsight Inc	3.40	$ 254.683 Millions	$ 74.952 Millions
Omada Health Inc	3.23	$ 243.151 Millions	$ 75.379 Millions
Transmedics Group Inc	3.22	$ 492.962 Millions	$ 152.857 Millions
Trisalus Life Sciences Inc	3.15	$ 41.057 Millions	$ 13.014 Millions
Procept Biorobotics Corporation	3.10	$ 218.369 Millions	$ 70.353 Millions
Carlsmed Inc	3.08	$ 56.207 Millions	$ 18.237 Millions
Neuropace Inc	3.08	$ 49.431 Millions	$ 16.070 Millions
Outset Medical Inc	3.07	$ 136.627 Millions	$ 44.453 Millions
Sharps Technology Inc	2.82	$ 7.478 Millions	$ 2.650 Millions
Edwards Lifesciences Corporation	2.81	$ 4,683.700 Millions	$ 1,664.300 Millions
Mimedx Group Inc	2.81	$ 120.791 Millions	$ 43.031 Millions
Streamex Corp	2.80	$ 26.248 Millions	$ 9.382 Millions
Pulse Biosciences Inc	2.74	$ 36.725 Millions	$ 13.395 Millions

Date modified: 2026-11-11T10:22:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.